Medical Device and Diagnostics
News & Jobs
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile


Immune Pharmaceuticals, Inc. 

150 Broadway
Suite 1801
New York  New York  10038  U.S.A.
Phone: 646-937-1941 Fax: n/a


 Company News
Immune Pharmaceuticals, Inc. Release: New Clinical Data Supports Development Of Bertilimumab In Both Ulcerative Colitis And Crohn's Disease 10/22/2014 8:01:23 AM
Immune Pharmaceuticals, Inc. Initiates Phase 2 Clinical Trial In Ulcerative Colitis 9/18/2014 8:28:02 AM
Immune Pharmaceuticals, Inc. Presenting At The 16th Annual Rodman & Renshaw Global Investment Conference, September 10, 2014 9/8/2014 8:42:58 AM
Immune Pharmaceuticals, Inc. Announces Approval For Listing On The NASDAQ Capital Market 8/19/2014 7:30:57 AM
Immune Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results And Provides Update On Bertilimumab Commencement Of Phase 2 Clinical Trials 8/14/2014 8:36:23 AM
Immune Pharmaceuticals, Inc. Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 7/30/2014 8:01:42 AM
Immune Pharmaceuticals, Inc. Release: Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 7/24/2014 9:04:54 AM
Immune Pharmaceuticals, Inc. Appoints Cameron Durrant, MD, MBA To Board Of Directors 7/14/2014 5:59:30 AM
Immune Pharmaceuticals, Inc. Partners With Patient Community Group LYFEBULB 6/25/2014 8:13:33 AM
Immune Pharmaceuticals, Inc. Appoints Gad Berdugo To Board Of Directors And Karin Hehenberger, M.D., Ph.D To Senior Vice President 6/6/2014 9:29:09 AM